Development of AZD5363, an inhibitor of AKT with activity in tumours containing mutations in the P13K-AKT pathway
Abstract not yet added
Date:
2 November 2015, 11:00 (Monday, 4th week, Michaelmas 2015)
Venue:
Old Road Campus Research Building, Headington OX3 7DQ
Venue Details:
71A, B and C
Speaker:
Dr Barry Davis ( AstraZeneca)
Organising department:
Department of Oncology
Organiser:
Linda Nemerofksy-Birks (University of Oxford)
Host:
Anderson Ryan (University of Oxford )
Part of:
Department of Oncology
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Amanda Chapman
